Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Maternal hypertensive disorders of pregnancy and childhood neurodevelopmental disorders: A two-sample Mendelian randomization

Submitted by Anna Hakala on Wed, 01/07/2026 - 10:00
  • Read more about Maternal hypertensive disorders of pregnancy and childhood neurodevelopmental disorders: A two-sample Mendelian randomization

The causal relationship between cathepsins and ankylosing spondylitis: a two-sample Mendelian randomization study

Submitted by Anna Hakala on Mon, 01/05/2026 - 15:56
  • Read more about The causal relationship between cathepsins and ankylosing spondylitis: a two-sample Mendelian randomization study

Genome Wide Association Analysis of Two Pore Domain Potassium Channel Gene Regions Reveals Multiple Pain-Associated Signals

Submitted by Anna Hakala on Mon, 01/05/2026 - 14:13
  • Read more about Genome Wide Association Analysis of Two Pore Domain Potassium Channel Gene Regions Reveals Multiple Pain-Associated Signals

Accelerated electrocardiographic aging of the heart as a risk determinant for atrial fibrillation: A Mendelian randomization study

Submitted by Anna Hakala on Mon, 01/05/2026 - 14:11
  • Read more about Accelerated electrocardiographic aging of the heart as a risk determinant for atrial fibrillation: A Mendelian randomization study

Helicobacter pylori infection is causally associated with extra-gastric tumors: a Mendelian randomization study

Submitted by Anna Hakala on Mon, 01/05/2026 - 09:25
  • Read more about Helicobacter pylori infection is causally associated with extra-gastric tumors: a Mendelian randomization study

Characterization of genetic loci associated with allergic conjunctivitis

Submitted by Anna Hakala on Mon, 01/05/2026 - 09:23
  • Read more about Characterization of genetic loci associated with allergic conjunctivitis

A two-sample Mendelian randomization study and mediation analysis exploring the link between cathepsins and epilepsy

Submitted by Anna Hakala on Mon, 01/05/2026 - 09:22
  • Read more about A two-sample Mendelian randomization study and mediation analysis exploring the link between cathepsins and epilepsy

Integrating polygenic and methylation risk scores for pleural mesothelioma risk stratification

Submitted by Anna Hakala on Mon, 01/05/2026 - 09:21
  • Read more about Integrating polygenic and methylation risk scores for pleural mesothelioma risk stratification

Genetic and functional evidence implicates a CRIP3 non-synonymous variant in age-related hearing loss

Submitted by Anna Hakala on Wed, 12/31/2025 - 09:24
  • Read more about Genetic and functional evidence implicates a CRIP3 non-synonymous variant in age-related hearing loss

Large-scale genetic analysis of age-related macular degeneration (AMD) drug targets highlights precision therapy opportunities for patients with high polygenic risk

Submitted by Anna Hakala on Wed, 12/31/2025 - 09:23
  • Read more about Large-scale genetic analysis of age-related macular degeneration (AMD) drug targets highlights precision therapy opportunities for patients with high polygenic risk

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Current page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement